Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Mechanism of action, anxiolytic and anticonvulsant activity of AWD-131-138

July 28, 1998

Effects of RGH-2716 on neurotransmitter release and cerebral energy metabolism

July 28, 1998

AIT-082: a new neuroregenerative compound

July 28, 1998

Novel gamma-aminobutyric acids related to gabapentin prepared at Warner-Lambert

July 28, 1998

Cognition-enhancing and antidepressant agent available from BTG

July 28, 1998

First report of neural stem cells forming functioning dopamine-producing neurons in culture

July 27, 1998

Longer treatment with EMLA associated with increased pain relief during cleansing of leg ulcers

July 27, 1998

Boehringer Ingelheim reports preliminary findings of ECASS II trial

July 27, 1998

Phosphonic acids that block EAA receptors: new series from Novartis

July 27, 1998

ALX-0646 development accelerated

July 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...